Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank van den Hoogen

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Arthritis Care & Research|November 5, 2011
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseJaap Fransen, Sindhu R Johnson, Frank van den Hoogen, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Arthritis and Rheumatism|April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trialPeter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Annals of the Rheumatic Diseases|December 13, 2016
Update of EULAR recommendations for the treatment of systemic sclerosisOtylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, et al.
Arthritis Care & Research|November 5, 2011
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseJaap Fransen, Sindhu R Johnson, Frank van den Hoogen, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Pageof 3